Evidence map›Paper›PMID 22997174›Full record

ArticleCerebral cortex (New York, N.Y. : 1991)2014

Homeostatic control of synaptic activity by endogenous adenosine is mediated by adenosine kinase.

Maria José Diógenes, Raquel Neves-Tomé, Sergio Fucile, Katiuscia Martinello, Maria Scianni, Panos Theofilas, Jan Lopatár, Joaquim A Ribeiro, Laura Maggi, Bruno G Frenguelli and 3 more

Open access · greenAbstract read
In one paragraph

Article in Cerebral cortex (New York, N.Y. : 1991), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 62 citations in OpenAlex.

  1. Neurocognitive and neurobiological effects of low dose organophosphate exposure.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  2. Selective modulation of epileptic tissue by an adenosine ABritish journal of pharmacology · 2024
    Article
  3. Adenosine ABiomolecules · 2023
    Article
  4. A maestro role of adenosine APurinergic signalling · 2022
    Article
  5. Discovery of Highly Potent Adenosine AACS chemical neuroscience · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Cell type-specific effects of adenosine on cortical neurons.Cerebral cortex (New York, N.Y. : 1991) · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 6 countries.

Maria José DiógenesInstitute of Pharmacology and Neurosciences, Faculty of Medicine and.
Raquel Neves-Tomé
Sergio Fucile
Katiuscia Martinello
Maria Scianni
Panos Theofilas
Jan Lopatár
Joaquim A Ribeiro
Laura Maggi
Bruno G Frenguelli
Cristina Limatola
Detlev Boison
Ana M Sebastião
University of Lisbon · PTFoundation University Islamabad · PKLegacy Health · USSapienza University of Rome · ITUniversity of Warwick · GBIstituto Neurologico Mediterraneo · IT

Funding

The Role of Adenosine in Ketogenic Diet TherapyR01NS065957 · NINDS · TRINITY COLLEGE · PI BOISON, DETLEV, GEIGER, JONATHAN DAVID · 2010 to 2021
$3.9M
Adenosine and schizophrenia: mechanisms and therapiesR01MH083973 · NIMH · LEGACY EMANUEL HOSPITAL AND HEALTH CENTER · PI BOISON, DETLEV · 2009 to 2015
$2.5M
Astrocyte dysfunction in epileptogenesis: the role of adenosineR01NS061844 · NINDS · LEGACY EMANUEL HOSPITAL AND HEALTH CENTER · PI BOISON, DETLEV · 2009 to 2013
$1.5M
NIMH NIH HHS R01 MH083973NINDS NIH HHS R01 NS061844NINDS NIH HHS R01-NS061844NINDS NIH HHS R01 NS065957
6 · The paper itself

Abstract

Extracellular adenosine, a key regulator of neuronal excitability, is metabolized by astrocyte-based enzyme adenosine kinase (ADK). We hypothesized that ADK might be an upstream regulator of adenosine-based homeostatic brain functions by simultaneously affecting several downstream pathways. We therefore studied the relationship between ADK expression, levels of extracellular adenosine, synaptic transmission, intrinsic excitability, and brain-derived neurotrophic factor (BDNF)-dependent synaptic actions in transgenic mice underexpressing or overexpressing ADK. We demonstrate that ADK: 1) Critically influences the basal tone of adenosine, evaluated by microelectrode adenosine biosensors, and its release following stimulation; 2) determines the degree of tonic adenosine-dependent synaptic inhibition, which correlates with differential plasticity at hippocampal synapses with low release probability; 3) modulates the age-dependent effects of BDNF on hippocampal synaptic transmission, an action dependent upon co-activation of adenosine A2A receptors; and 4) influences GABAA receptor-mediated currents in CA3 pyramidal neurons. We conclude that ADK provides important upstream regulation of adenosine-based homeostatic function of the brain and that this mechanism is necessary and permissive to synaptic actions of adenosine acting on multiple pathways. These mechanistic studies support previous therapeutic studies and implicate ADK as a promising therapeutic target for upstream control of multiple neuronal signaling pathways crucial for a variety of neurological disorders.

Indexed as

AdenosineAdenosine KinaseAnimalsBlotting, WesternBrain-Derived Neurotrophic FactorCA1 Region, HippocampalCA3 Region, HippocampalElectrophysiological PhenomenaExcitatory Postsynaptic PotentialsExtracellular SpaceHomeostasisImmunohistochemistryMiceMice, Inbred C57BLMice, TransgenicMossy Fibers, HippocampalAdenosineAdenosine KinaseBrain-Derived Neurotrophic FactorPurinesReceptor, Adenosine A2AReceptors, GABA-Aadenosinebrain-derived neurotrophic factorGABAhomeostasistransgenic mice

Identifiers

PMID22997174
PMCPMC3862265
OpenAlexW2099530938

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.